Financial Performance

A new partnership aims to replace needles with pills for a powerful class of drugs, using advanced AI to solve a multi-billion dollar challenge in medicine.

A Dutch medtech firm is advancing a pivotal study for its VCFix® system, a device that aims to reconstruct vertebrae rather than just fill them.

A new real-time index from AI firm Quandri reveals a dramatic slowdown in home insurance premium increases, though relief is uneven across the country.

Belmont Medical's acquisition of Arcos fuses life-saving devices with smart software, promising a new era of data-driven care for trauma and burn patients.

Autonomique's AI robots are moving beyond demos to build car parts for a Tier-1 supplier, signaling a structural shift in manufacturing automation.

Majestic Steel is expanding into decking, a strategic move to become a one-stop shop for the data centers and warehouses defining our digital future.

Applied Atomics revives BWXT's shelved mPower reactor, betting its modular design can quench the insatiable thirst of data centers. But can it win the race?

Flexstone Partners' acquisition of Glouston creates a $15B giant, signaling a strategic shift in private equity and a major win for parent company Natixis.

Sony and CJ 4DPLEX's new on-set collaboration for 'Spider-Man' is more than a gimmick. It's a strategic play to redefine the premium cinema experience.

EdTech firm Risepoint just won four Comparably awards. We look at how its remote-first model and focus on leadership are creating a blueprint for success.

Coverys adds M&A heavyweight Michael Boguski to its board, a clear signal the MPL insurer is gearing up for strategic maneuvers in a volatile market.

At Automate 2026, Telit Cinterion demos an AI suite that gives factories autonomous decision-making power, reducing cloud reliance and boosting resilience.

WesBanco's inclusion in the S&P SmallCap 600 isn't just a milestone; it's a playbook on strategic growth and a key signal for investors in a shifting market.

Flip's new identity and AI tools aren't just an upgrade; they're a strategic move to solve the security and productivity crisis facing 2.7 billion workers.

Gelteq aims to replace needles with its ingestible gel, targeting diabetes and more. But can it balance this lofty goal with near-term revenue and tight finances?

As federal support for science wanes, the National Cancer Center adds top minds from Stanford and Harvard to identify and fund the next wave of cancer cures.

Toronto-based Augmenta has launched ACP 2.0, an AI platform that claims to slash electrical design work from weeks to hours, offering a strategic solution to labor shortages.

Echo Global Logistics' new intra-Mexico service tackles historical supply chain fragmentation, offering a seamless, tech-driven solution for the booming nearshoring economy.

As a key architect of its growth retires, Progressive's leadership shuffle reveals a deliberate strategy to fuse customer data with its core business.

An Israeli biotech just published a patent for a 'mucoadhesive' gel that makes drugs stick inside the nose. It's a key step in a multi-billion dollar race.